Floatz logo

FENTANYL

Arterial Occlusive Diseases

University of Sao Paulo General HospitalSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Arterial Occlusive Diseases cohort.

Asset / SponsorPhaseRating
3-N-BUTYLPHTHALIDE
The Second Hospital of Hebei Medical University
Phase 4BB
Recombinant Human Plasminogen Activator
The First Affiliated Hospital with Nanjing Medical University
Phase 3B
Tenecteplase
Beijing Tiantan Hospital
Phase 3B
Recombinant Human Plasminogen Activator
The First Affiliated Hospital with Nanjing Medical University
Phase 3B
ROPIVACAINE
University of Sao Paulo General Hospital
Phase 3B

View all 10 →

Same molecule, other indications

FENTANYL is also rated in:

Low Back PainDormant
BBB
Indicative ·
75 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →